Skip to main content
Equibles

JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · Documents

Use JAGSNPHARM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JAGSNPHARM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
216.15 INR -0.58 (-0.27%) At close · Nov 13
Rebalance outlook locked
Market Cap
14.26B INR
Shares
65.96M
Volume · Nov 13 24.54K Avg daily vol (3M) 242.65K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 29, 2026
2026
Oct 29
Earnings call
Q2 2027 earnings call

Jaxampal Pharmaceuticals Ltd. reported organic growth of 9.3%, H1 EBITDA margin of 22.9% and cash and bank balance of 135 crores. It targets Rs. 500 crore by FI 2028 and Q3 revenue crossing 100 crores with consolidated EBITDA margin above 22%.

Showing 1–3 of 3 documents